Literature DB >> 30183553

Injury of Adult Zebrafish Expressing Acvr1lQ204D Does Not Result in Heterotopic Ossification.

Melissa LaBonty1,2, Nicholas Pray2, Pamela C Yelick1,2.   

Abstract

Fibrodysplasia Ossificans Progressiva (FOP) is a rare, autosomal dominant genetic disorder in humans characterized by the gradual ossification of fibrous tissues, including skeletal muscle, tendons, and ligaments. In humans, mutations in the Type I BMP/TGFβ family member receptor gene, ACVR1, are associated with FOP. Zebrafish acvr1l, previously known as alk8, is the functional ortholog of human ACVR1. We previously created and characterized the first adult zebrafish model for FOP by generating animals harboring heat shock-inducible mCherry-tagged constitutively active Acvr1l (Q204D). Since injury is a known trigger for heterotopic ossification (HO) development in human FOP patients, in this study, we investigated several injury models in Acvr1lQ204D-expressing zebrafish and the subsequent formation of HO. We performed studies of Activin A injection, cardiotoxin (CTX) injection, and caudal fin clip injury. We found that none of these methods resulted in HO formation at the site of injury. However, some of the cardiotoxin-injected and caudal fin-clipped animals did exhibit HO at distant sites, including the body cavity and along the spine. We describe these results in the context of new and exciting reports on FOP, and discuss future studies to better understand the etiology and progression of this disease.

Entities:  

Keywords:  activating ACVR1 mutations; fibrodysplasia ossificans progressiva; heterotopic ossification

Mesh:

Substances:

Year:  2018        PMID: 30183553      PMCID: PMC6277083          DOI: 10.1089/zeb.2018.1611

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  50 in total

Review 1.  The myofibroblast in wound healing and fibrocontractive diseases.

Authors:  G Gabbiani
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

2.  zALK-8, a novel type I serine/threonine kinase receptor, is expressed throughout early zebrafish development.

Authors:  P C Yelick; T S Abduljabbar; P Stashenko
Journal:  Dev Dyn       Date:  1998-04       Impact factor: 3.780

3.  The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.

Authors:  Jaymin Upadhyay; LiQin Xie; Lily Huang; Nanditha Das; Rachel C Stewart; Morgan C Lyon; Keryn Palmer; Saathyaki Rajamani; Chris Graul; Merryl Lobo; Tyler J Wellman; Edward J Soares; Matthew D Silva; Jacob Hesterman; Lili Wang; Xialing Wen; Xiaobing Qian; Kalyan Nannuru; Vincent Idone; Andrew J Murphy; Aris N Economides; Sarah J Hatsell
Journal:  J Bone Miner Res       Date:  2017-09-22       Impact factor: 6.741

4.  Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification.

Authors:  Devaveena Dey; Jana Bagarova; Sarah J Hatsell; Kelli A Armstrong; Lily Huang; Joerg Ermann; Ashley J Vonner; Yue Shen; Agustin H Mohedas; Arthur Lee; Elisabeth M W Eekhoff; Annelies van Schie; Marie B Demay; Charles Keller; Amy J Wagers; Aris N Economides; Paul B Yu
Journal:  Sci Transl Med       Date:  2016-11-23       Impact factor: 17.956

5.  Substance P signaling mediates BMP-dependent heterotopic ossification.

Authors:  Lixin Kan; Vitali Y Lounev; Robert J Pignolo; Lishu Duan; Yijie Liu; Stuart R Stock; Tammy L McGuire; Bao Lu; Norma P Gerard; Eileen M Shore; Frederick S Kaplan; John A Kessler
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

6.  Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.

Authors:  Salin A Chakkalakal; Kenta Uchibe; Michael R Convente; Deyu Zhang; Aris N Economides; Frederick S Kaplan; Maurizio Pacifici; Masahiro Iwamoto; Eileen M Shore
Journal:  J Bone Miner Res       Date:  2016-03-12       Impact factor: 6.741

7.  ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.

Authors:  Sarah J Hatsell; Vincent Idone; Dana M Alessi Wolken; Lily Huang; Hyon J Kim; Lili Wang; Xialing Wen; Kalyan C Nannuru; Johanna Jimenez; Liqin Xie; Nanditha Das; Genevieve Makhoul; Rostislav Chernomorsky; David D'Ambrosio; Richard A Corpina; Christopher J Schoenherr; Kieran Feeley; Paul B Yu; George D Yancopoulos; Andrew J Murphy; Aris N Economides
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

8.  Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.

Authors:  Haitao Wang; Carter Lindborg; Vitali Lounev; Jung-Hoon Kim; Ruth McCarrick-Walmsley; Meiqi Xu; Laura Mangiavini; Jay C Groppe; Eileen M Shore; Ernestina Schipani; Frederick S Kaplan; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2016-04-20       Impact factor: 6.741

Review 9.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 10.  The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.

Authors:  Dana M Alessi Wolken; Vincent Idone; Sarah J Hatsell; Paul B Yu; Aris N Economides
Journal:  Bone       Date:  2017-06-16       Impact factor: 4.398

View more
  2 in total

Review 1.  Fibrodysplasia ossificans progressiva: current concepts from bench to bedside.

Authors:  Arun-Kumar Kaliya-Perumal; Tom J Carney; Philip W Ingham
Journal:  Dis Model Mech       Date:  2020-09-21       Impact factor: 5.758

Review 2.  Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders.

Authors:  Takenobu Katagiri; Sho Tsukamoto; Mai Kuratani
Journal:  Biomedicines       Date:  2021-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.